Delen, L. Et Al. 2022. Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality. MARMARA MEDICAL JOURNAL , vol.35, no.3 , 308-315.

Delen, L., Kasapoglu, U. S., Gok, A., Cagasar, O., TETİK, B., & Oksuz, E., (2022). Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality. MARMARA MEDICAL JOURNAL , vol.35, no.3, 308-315.

Delen, Leman Et Al. "Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality," MARMARA MEDICAL JOURNAL , vol.35, no.3, 308-315, 2022

Delen, Leman Et Al. "Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality." MARMARA MEDICAL JOURNAL , vol.35, no.3, pp.308-315, 2022

Delen, L. Et Al. (2022) . "Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality." MARMARA MEDICAL JOURNAL , vol.35, no.3, pp.308-315.

@article{article, author={Leman Delen Et Al. }, title={Efficacy of tocilizumab therapy in severe COVID-19 pneumonia patients and determination of the prognostic factors affecting 30 days mortality}, journal={MARMARA MEDICAL JOURNAL}, year=2022, pages={308-315} }